Hosseini Seyed Taleb, Mahmanzar Mohammadamin, Rahimian Karim, Bayat Saleha, Gholamzad Amir, Sisakht Mahsa Mollapour, Farhadi Amin, Kuehu Donna Lee, Deng Youping
Medicinal Plants Research Center, Institute of Herbal Medicines and Metabolic Disorders, Mazandaran University of Medical Sciences, Sari, Iran.
Department of Quantitative Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, USA.
J Med Virol. 2025 Sep;97(9):e70586. doi: 10.1002/jmv.70586.
RNA viruses have high mutation frequency, quick generation periods and vast population numbers, which promote fast evolution and host environment adaptation. We integrated scRNA-seq and spatial transcriptomics to profile immune cells and viral gene expression in COVID-19. Cell types and interactions were identified using Seurat-based tools. Spatial transcriptomics analysis revealed viral hotspots, and GISAID data were used to track SARS-CoV-2 mutations. Single-cell and spatial transcriptomics analyses revealed that immune cells such as Neutrophils, Monocyte:CD14 + , and T cell:CD4+ central memory are highly abundant in COVID-19 patients, particularly in mild and severe cases, and are concentrated in the central and upper regions of lung tissue. Pseudotime and CellChat analyses indicated that cell differentiation trajectories and communication networks shift toward heightened inflammatory responses in severe conditions. Spatial analysis of viral gene expression showed that SARS-CoV-2 genes, especially Nucleoprotein, Spike and Envelope were highly expressed in central and upper-right tissue regions, suggesting active viral replication. This localized viral activity was strongly associated with areas of immune cell infiltration and inflammation. The top 10 sustainable mutants in SARS-CoV-2 genome with high frequency were observed in NSP12 (P323L, 99%, Switzerland), Spike (D614G, 97%, Switzerland), NSP4 (T492I, 79%, Switzerland), NSP6 (T77A, 70%, Guangdong), Orf9c (G50N, 64%, England), Nucleoprotein (D377Y, 62%, United States), Orf9b (T60A, 61%, France), NSP14 (I42V, 55%, United States), Envelope (T9I, 51.3%, Trinidad and Tobago), and NSP5 (P132H, 51.2%, United States). Following to this approach is crucial for a strong epidemiological reaction against the changing SARS-CoV-2 outbreak.
RNA病毒具有高突变频率、短世代周期和庞大种群数量,这促进了其快速进化和对宿主环境的适应。我们整合了单细胞RNA测序(scRNA-seq)和空间转录组学技术,以描绘新冠病毒(COVID-19)中免疫细胞和病毒基因的表达情况。使用基于Seurat的工具鉴定细胞类型和细胞间相互作用。空间转录组学分析揭示了病毒热点区域,并利用全球共享流感数据倡议组织(GISAID)的数据追踪严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的突变情况。单细胞和空间转录组学分析表明,中性粒细胞、单核细胞:CD14+以及T细胞:CD4+中央记忆等免疫细胞在COVID-19患者中高度富集,尤其是在轻症和重症病例中,且集中在肺组织的中央和上部区域。伪时间分析和CellChat分析表明,在重症情况下,细胞分化轨迹和通讯网络向增强的炎症反应转变。病毒基因表达的空间分析显示,SARS-CoV-2基因,尤其是核蛋白、刺突蛋白和包膜蛋白在中央和右上组织区域高度表达,表明病毒正在活跃复制。这种局部病毒活性与免疫细胞浸润和炎症区域密切相关。在SARS-CoV-2基因组中观察到频率较高的前10个持续性突变体分别位于非结构蛋白12(NSP12,P323L,99%,瑞士)、刺突蛋白(D614G,97%,瑞士)、NSP4(T492I,79%,瑞士)、NSP6(T77A,70%,广东)、开放阅读框9c(Orf9c,G50N,64%,英国)、核蛋白(D377Y,62%,美国)、Orf9b(T60A,61%,法国)、NSP14(I42V,55%,美国)、包膜蛋白(T9I,51.3%,特立尼达和多巴哥)以及NSP5(P132H,51.2%,美国)。遵循这种方法对于针对不断变化的SARS-CoV-2疫情做出强有力的流行病学反应至关重要。